0001493152-22-035570.txt : 20221215
0001493152-22-035570.hdr.sgml : 20221215
20221215161517
ACCESSION NUMBER: 0001493152-22-035570
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221214
FILED AS OF DATE: 20221215
DATE AS OF CHANGE: 20221215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KOSKI ROBERT C
CENTRAL INDEX KEY: 0001234880
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32188
FILM NUMBER: 221464978
MAIL ADDRESS:
STREET 1: 1500 W UNIVERSITY PARKWAY
CITY: SARASOTA
STATE: FL
ZIP: 34243
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAGENICS INC
CENTRAL INDEX KEY: 0001174940
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 593410522
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
BUSINESS PHONE: 8132867900
MAIL ADDRESS:
STREET 1: 4902 EISENHOWER BLVD
STREET 2: SUITE 125
CITY: TAMPA
STATE: FL
ZIP: 33634
4
1
ownership.xml
X0306
4
2022-12-14
0
0001174940
ORAGENICS INC
OGEN
0001234880
KOSKI ROBERT C
4902 EISENHOWER BOULEVARD
TAMPA
FL
33634
1
0
0
0
Common Stock
2022-12-14
4
S
0
4503
0.1750
D
1310149
I
See footnote
Common Stock
212839
D
The price reported in Column 4 was the weighted average price on the Transaction Date indicated. The shares were sold in multiple transactions ranging from $0.1700 to $0.1800 on the Transaction Date. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents shares owned by the Koski Family Limited Partnership ("KFLP"). The reporting person serves as one of the general partners of the KFLP and disclaims beneficial ownership of the securities reflected as held by the KFLP except to the extent of the reporting person's pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
Shares owned directly by Robert C. Koski, a director of the Company. An aggregate of 53,086 shares held by individual trusts for reporting person's five children and previously reflected as part of reporting person's indirect beneficial ownership have been excluded from the reporting person's beneficial ownership as the reporting person no longer serves as trustee for the trusts.
/s/ Mark A. Catchur, as Attorney-in-Fact for Robert C. Koski
2022-12-15